NCT07005648 Brazilian Registry of Menopausal Health
| NCT ID | NCT07005648 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Science Valley Research Institute |
| Condition | Menopause |
| Study Type | OBSERVATIONAL |
| Enrollment | 1,592 participants |
| Start Date | 2026-06-30 |
| Primary Completion | 2026-12-30 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 1,592 participants in total. It began in 2026-06-30 with a primary completion date of 2026-12-30.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
The Brazilian Registry of Menopausal Health is a national study aimed to better understand the health and quality of life of participants aged 35 to 65 who are in the menopausal transition or postmenopausal phase, including cisgender women and transgender men. The study's hypothesis is that significant regional and socioeconomic disparities influence individuals' health, knowledge, and perception of menopause.
Eligibility Criteria
Inclusion Criteria: 1. Women aged between 35 and 65 years attending medical consultation at public and private outpatient health services; 2. Ability to confirm voluntary participation and sign the Informed Consent Form Exclusion Criteria: 1. Inability to respond to the interview for any reason 2. Suspected or confirmed pregnancy 3. Lactation 4. Uncontrolled diabetes 5. Uncontrolled arterial hypertension 6. Uncontrolled thyroid disorders 7. Grade 3 obesity, defined by a BMI equal to or greater than 40.0 kg/m² 8. Diagnosis of psychiatric disorders that may compromise participation in the interview 9. Previous hysterectomy 10. Previous oophorectomy 11. Current use of illicit drugs
Contact & Investigator
Fabiane B de Souza, MD
PRINCIPAL INVESTIGATOR
Science Valley Research Institute
Frequently Asked Questions
Who can join the NCT07005648 clinical trial?
This trial is open to participants of all sexes, aged 35 Years or older, up to 65 Years, studying Menopause. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT07005648 currently recruiting?
Yes, NCT07005648 is actively recruiting participants. Contact the research team at agati@svriglobal.com for enrollment information.
Where is the NCT07005648 trial being conducted?
This trial is being conducted at São Paulo, Brazil.
Who is sponsoring the NCT07005648 clinical trial?
NCT07005648 is sponsored by Science Valley Research Institute. The principal investigator is Fabiane B de Souza, MD at Science Valley Research Institute. The trial plans to enroll 1,592 participants.